116 related articles for article (PubMed ID: 12559513)
1. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis.
Petereit HF; Pukrop R; Fazekas F; Bamborschke SU; Röpele S; Kölmel HW; Merkelbach S; Japp G; Jongen PJ; Hartung HP; Hommes OR
J Neurol Sci; 2003 Feb; 206(2):209-14. PubMed ID: 12559513
[TBL] [Abstract][Full Text] [Related]
2. TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.
Killestein J; Kalkers NF; Meilof JF; Barkhof F; van Lier RA; Polman CH
Neurology; 2001 Sep; 57(6):1129-31. PubMed ID: 11571353
[TBL] [Abstract][Full Text] [Related]
3. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
4. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
Killestein J; Eikelenboom MJ; Izeboud T; Kalkers NF; Adèr HJ; Barkhof F; Van Lier RA; Uitdehaag BM; Polman CH
J Neuroimmunol; 2003 Sep; 142(1-2):141-8. PubMed ID: 14512173
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
6. Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Kallaur AP; Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Lopes J; de Carvalho Jennings Pereira WL; de Meleck Proença C; Borelli SD; Kaimen-Maciel DR; Maes M; Reiche EMV
Mol Neurobiol; 2017 May; 54(4):2950-2960. PubMed ID: 27023227
[TBL] [Abstract][Full Text] [Related]
7. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis.
Eikelenboom MJ; Killestein J; Uitdehaag BM; Polman CH
Mult Scler; 2005 Oct; 11(5):520-3. PubMed ID: 16193888
[TBL] [Abstract][Full Text] [Related]
9. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
[TBL] [Abstract][Full Text] [Related]
10. Cytokine analysis in multiple sclerosis by competitive RT - PCR: A decreased expression of IL-10 and an increased expression of TNF-alpha in chronic progression.
Huang WX; Huang P; Link H; Hillert J
Mult Scler; 1999 Oct; 5(5):342-8. PubMed ID: 10516778
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
[TBL] [Abstract][Full Text] [Related]
12. Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.
Khoury SJ; Guttmann CR; Orav EJ; Kikinis R; Jolesz FA; Weiner HL
Arch Neurol; 2000 Aug; 57(8):1183-9. PubMed ID: 10927799
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume.
Prat A; Pelletier D; Duquette P; Arnold DL; Antel JP
Ann Neurol; 2000 Feb; 47(2):234-7. PubMed ID: 10665495
[TBL] [Abstract][Full Text] [Related]
14. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.
Minneboo A; Jasperse B; Barkhof F; Uitdehaag BM; Knol DL; de Groot V; Polman CH; Castelijns JA
J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):917-23. PubMed ID: 18077480
[TBL] [Abstract][Full Text] [Related]
15. T cells involved in psoriasis vulgaris belong to the Th1 subset.
Schlaak JF; Buslau M; Jochum W; Hermann E; Girndt M; Gallati H; Meyer zum Büschenfelde KH; Fleischer B
J Invest Dermatol; 1994 Feb; 102(2):145-9. PubMed ID: 8106745
[TBL] [Abstract][Full Text] [Related]
16. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
[TBL] [Abstract][Full Text] [Related]
17. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
18. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Paling D; Solanky BS; Riemer F; Tozer DJ; Wheeler-Kingshott CA; Kapoor R; Golay X; Miller DH
Brain; 2013 Jul; 136(Pt 7):2305-17. PubMed ID: 23801742
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis.
Choi IY; Lee P; Hughes AJ; Denney DR; Lynch SG
Mult Scler; 2017 Jun; 23(7):956-962. PubMed ID: 27620894
[TBL] [Abstract][Full Text] [Related]
20. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
